Objective: To compare the costs associated with 2 clinical strategies in children with recurrent upper respiratory tract infections (URTIs): immediate adenoidectomy vs an initial watchful waiting strategy.
Design: A cost-minimization analysis from a societal perspective including both direct and indirect costs, alongside an open randomized controlled trial with a 2-year follow-up.
Setting: Multicenter study, including 11 general and 2 university hospitals in the Netherlands.
Patients: The study population comprised 111 children aged 1 through 6 years, selected for adenoidectomy for recurrent URTIs according to current clinical practice.
Intervention: A strategy of immediate adenoidectomy with or without myringotomy or a strategy of initial watchful waiting.
Main Outcomes Measures: Difference in median costs during the 2-year follow-up.
Results: The median total of direct and indirect costs in the adenoidectomy and watchful waiting group were €1385 (US $1995) and €844 (US $1216) per patient, respectively. The extra costs in the adenoidectomy group are primarily attributable to surgery and visits to the otorhinolaryngologist. Other costs did not differ significantly between the groups.
Conclusions: In children selected for adenoidectomy for recurrent URTIs, immediate adenoidectomy results in an increase in costs, whereas it confers no clinical benefit over an initial watchful waiting strategy.
Trial Registration: trialregister.nl Identifier:NTR968; isrctn.org Identifier:ISRCTN03720485.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/jamaoto.2013.1324 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!